L'Oréal Says Weight-Loss Drugs Are Affecting Beauty and Skincare Sales

L'Oréal's chief executive has said that the use of GLP-1 weight-loss drugs is having an impact on the company's beauty and skincare business. He described the trend as a very important development for the company. The article provided limited further detail beyond this statement. The remarks highlight how the growing popularity of these medications is beginning to reach sectors outside healthcare.
This is an AI-generated summary. ShortSingh links to the original source for the complete article.




Discussion (0)
Log in to join the discussion and vote.
Log in